- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Triple-Negative Breast Cancer
Total 16202 results
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Merck Sharp & Dohme LLCNot yet recruitingTriple-Negative Breast Cancer
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
First Affiliated Hospital Bengbu Medical CollegeRecruitingTriple-negative Breast CancerChina
-
Sichuan Provincial People's HospitalRecruitingTriple-negative Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingTriple-negative Breast CancerChina
-
Texas Tech University Health Sciences Center, El...RecruitingTriple-negative Breast CancerUnited States
-
Fudan UniversityRecruitingTriple-negative Breast CancerChina
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Laura KennedyNational Cancer Institute (NCI)SuspendedBreast Cancer | Triple-negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdCompletedTriple-negative Breast CancerChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University of Milan; European Institute of Oncology; IFOM, The FIRC Institute...Active, not recruitingTriple-negative Breast CancerItaly
-
Guangdong Provincial People's HospitalCompletedTriple-Negative Breast CancerChina
-
Fudan UniversityActive, not recruiting
-
Tianjin Medical University Cancer Institute and...UnknownTriple-negative Breast CancerChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakedaTerminatedTriple-Negative Breast CancerAustria
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
BioNTech SESeventh Framework ProgrammeCompletedBreast Cancer (Triple Negative Breast Cancer (TNBC))Sweden, Germany
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZenecaRecruitingEarly Small (cT1N0) Triple Negative Breast CancerFrance
-
George T. BuddUnited States Department of Defense; Anixa Biosciences, Inc.RecruitingResidual Disease | TNBC - Triple-Negative Breast Cancer | Pathologic Stage IIA-IIIC Triple-Negative Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast CarcinomaUnited States
-
Virginia Commonwealth UniversityEli Lilly and Company; BayerTerminatedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Huihua XiongRecruiting
-
Ministry of Health, Saudi ArabiaMaher M.aklNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingAdvanced Triple Negative Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingBreast Cancer | TNBC - Triple-Negative Breast Cancer
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBreast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Invasive | Breast Cancer Triple NegativeUnited States
-
Gilead SciencesWithdrawnTriple-negative Breast Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Hebei Medical University Fourth HospitalBeijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.UnknownBreast Cancer | Triple-negative Breast Cancer | Nab-paclitaxelChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedTriple-negative Breast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
First Affiliated Hospital of Zhejiang UniversityShanghai Longfine Biotechnology Co., Ltd.; TopAllianceNot yet recruitingTriple-negative Breast CancerChina
-
Priyanka SharmaBristol-Myers Squibb; Celgene CorporationActive, not recruitingBreast Cancer | Triple-Negative Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); American College of Radiology Imaging NetworkActive, not recruitingStage II Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast CancerUnited States
-
Institut Claudius RegaudActive, not recruitingTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
Wuhan Union Hospital, ChinaRecruitingTriple-negative Breast Cancer | CadonilimabChina